Who owns Neurocrine Biosciences Inc Note 2.250 5/1?
- CUSIP Number: 64125cad1
Tip: Access positions for across all investors
Analyze quarterly positions in Neurocrine Biosciences Inc Note 2.250 5/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurocrine Biosciences Inc Note 2.250 5/1 stock
Who bought or sold Neurocrine Biosciences Inc Note 2.250 5/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 55M | $95M | 0% | Dec 2023 |
|
| Tenor Capital Management | 27M | $47B | 0% | Dec 2023 |
|
| D. E. Shaw & Co | 14M | $25M | 0% | Dec 2023 |
|
| Lord, Abbett & Co | 12M | $21M | 164% | Dec 2023 |
|
| CSS | 8.9M | $15M | -43% | Dec 2023 |
|
| SSI Investment Management | 2.3M | $3.9M | -1% | Dec 2023 |
|
| Bnp Paribas Investment Partners | 1.6M | $2.8M | -48% | Dec 2023 |
|
| Two Sigma Investments | 1.5M | $2.6M | 100% | Dec 2023 |
|
| Agf Management | 1.2M | $2.1M | 71% | Dec 2023 |
|
| Citigroup | 962k | $1.7M | 946% | Dec 2023 |
|
| Sunrise Partners Limited Partnership | 847k | $1.5M | -73% | Dec 2023 |
|
| Barclays | 562k | $974k | 18% | Dec 2023 |
|
| Jane Street | 213k | $371k | -18% | Dec 2023 |
|
| Fox Hill Wealth Management | 134k | $242k | 4% | Mar 2024 |
|
| Royal Bank of Canada | 106k | $177k | 0% | Dec 2023 |
|
| First Hawaiian Bank | 47k | $85k | 0% | Mar 2024 |
|
| Us Bancorp | 31k | $53k | 0% | Dec 2023 |
|
| Virtus Investment Advisers | 26k | $45k | 100% | Dec 2023 |
|
| Bank of America Corporation | 4.0k | $6.9k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 4.0k | $6.9k | -93% | Dec 2023 |
|
| Wells Fargo & Company | 3.0k | $5.2k | 0% | Dec 2023 |
|
| Capital Analysts | 2.0k | $3.0k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 1.0k | $1.7k | 0% | Dec 2023 |
|
Who sold out of Neurocrine Biosciences Inc Note 2.250 5/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Warberg Asset Management | Sep 2023 | 1.3M | $1.9M |
| UBS Group | Sep 2023 | 1.0k | $1.5k |